Innovation Medical(002173)2025-02-25 10:10Financial Performance Expectations - The company expects a net loss of between 65 million and 50 million yuan for the fiscal year 2024, compared to a loss of 34.29 million yuan in the same period last year, representing a decline of 45.82% to 89.57% year-over-year [4] - The net profit after deducting non-recurring gains and losses is projected to be a loss of between 67 million and 52 million yuan, down from a loss of 28.00 million yuan last year, indicating a decrease of 85.70% to 139.26% [4] - The basic earnings per share are expected to be a loss of between 0.15 yuan and 0.11 yuan, compared to a loss of 0.08 yuan per share in the previous year [4] - The company's operating revenue is forecasted to be between 800 million and 830 million yuan, slightly down from 805.59 million yuan in the previous year [4] Factors Affecting Profitability - The decline in profitability is attributed to the ongoing impact of medical insurance payment reform, which has led to a decrease in overall service charges and a drop in gross profit margin [6][7] Communication and Risks - The company has communicated with its accounting firm regarding the earnings forecast, and there are no discrepancies in this regard [5] - The company warns of potential risks related to ongoing litigation involving Shenzhen Qianhai Zhuoyue Financing Leasing Co., Ltd., which may affect its financial position [8] - The financial data provided in the earnings forecast is preliminary and subject to change pending the audited annual report for 2024 [8]